Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients
N Reizine, K Danahey, E Schierer, P Liu… - The …, 2021 - academic.oup.com
Background Several opioids have pharmacogenomic associations impacting analgesic
efficacy. However, germline pharmacogenomic testing is not routinely incorporated into …
efficacy. However, germline pharmacogenomic testing is not routinely incorporated into …